Skip to content

Tan Reduction of D-Tan Facial

A Clinical Study to Evaluation Of Tan Reduction Potential of Ozone D-Tan Facial Cleanser on Healthy Human Volunteers - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/074775
Enrollment
32
Registered
2024-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: D Tan Facial Cleanser: Test Product: D Tan Facial Cleanser, Dose: Take sufficient quanity, apply on wet skin and neck massage gently for 10-15 minutes, thereafter wash it

Sponsors

Ozone Pharmaceuticals Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Gender: Male or Female with age 18-45 2)Subjects with mild pigmentation and tan. 3)Subjects willing to give written informed consent 4)Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 5)Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 6)Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 3.Have open sores or open lesions in the treatment area(s). 4.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 5.Have participated in any interventional clinical trial in the previous 90 days. 6.Have a known sensitivity to any of the constituents of the test product including sensitivities 7.Have used, are using, or are planning to use.

Design outcomes

Primary

MeasureTime frame
1.Skin Lightness- by Spectrophotometer 2. Instant Skin Detain 3. Instant melanin ReductionTimepoint: At T0, T15min

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026